WCG, a leading provider of clinical research solutions, has recently unveiled Total Feasibility, a new application on their ClinSphere technology platform designed to revolutionize the site feasibility process. The purpose of this cutting-edge solution is to facilitate the quick development of clinical study feasibility questionnaires, enhance the matching of sites to studies, reduce duplication, and speed up response times from potential sites.
Cristin MacDonald, Ph.D., Vice President of Client Delivery at WCG, highlights how Total Feasibility streamlines questionnaires for sponsors and CROs by reducing repetitive questions and promoting greater collaboration among stakeholders. This helps streamline the site selection process and reduces the burden on sites.
Terri Moench, President of Clinical Research Solutions at WCG, emphasizes that Total Feasibility offers valuable data and insights beyond therapeutic area and indication. With this new functionality, sponsors and CROs can access detailed insights that traditional solutions on the market do not provide. This enables more informed study planning and site identification activities.
Total Feasibility was created to address the challenges faced by sites and investigators during the assessment process. Through efficient data collection, smooth workflows, and automated procedures, it offers faster outcomes that benefit both sponsors and CROs in decision-making processes in study planning and site selection through data-driven solutions.
